Literature DB >> 18281613

Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene.

Waldo Herrera1, Tomas S Aleman, Artur V Cideciyan, Alejandro J Roman, Eyal Banin, Tamar Ben-Yosef, Leigh M Gardner, Alexander Sumaroka, Elizabeth A M Windsor, Sharon B Schwartz, Edwin M Stone, Xue-Zhong Liu, William J Kimberling, Samuel G Jacobson.   

Abstract

PURPOSE: To determine the retinal phenotype of Usher syndrome type III (USH3A) caused by clarin-1 (CLRN1) gene mutations in a non-Finnish population.
METHODS: Patients with USH3A (n = 13; age range, 24-69) representing 11 different families were studied and the results compared with those from patients with USH2A (n = 24; age range, 17-66). The patients were evaluated by ocular examination, kinetic and static perimetry, near-infrared autofluorescence, and optical coherence tomography (OCT).
RESULTS: Ten of 11 families had Ashkenazi Jewish origins and the N48K CLRN1 mutation. Rod function was lost in the peripheral field in the first two decades of life, but central rod function could be retained for another decade. Peripheral cone function was detectable into the third decade of life. Central cone function had a slower decline that extended for decades. Photoreceptor layer loss and features of retinal remodeling were present in retinal regions with severe visual dysfunction, even at the youngest ages tested. Central retinal structure could be normal in younger patients but structural integrity was lost in older patients. RPE disease generally paralleled photoreceptor degeneration. Comparisons between USH3A and USH2A suggested a common rod and cone phenotype but a more accelerated time course of rod loss in USH3A.
CONCLUSIONS: USH3A and USH2A share patterns of rod and cone dysfunction and retinal structural abnormalities. Peripheral function measurements showed USH3A to be more rapidly progressive than USH2A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281613     DOI: 10.1167/iovs.07-1505

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  44 in total

1.  Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Authors:  Peter J Francis; Brian Mansfield; Stephen Rose
Journal:  Transl Vis Sci Technol       Date:  2013-11-21       Impact factor: 3.283

2.  Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome.

Authors:  Edwin M Stone; Artur V Cideciyan; Tomas S Aleman; Todd E Scheetz; Alexander Sumaroka; Mary A Ehlinger; Sharon B Schwartz; Gerald A Fishman; Elias I Traboulsi; Byron L Lam; Anne B Fulton; Robert F Mullins; Val C Sheffield; Samuel G Jacobson
Journal:  Arch Ophthalmol       Date:  2011-01

Review 3.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

4.  RPGR-associated retinal degeneration in human X-linked RP and a murine model.

Authors:  Wei Chieh Huang; Alan F Wright; Alejandro J Roman; Artur V Cideciyan; Forbes D Manson; Dina Y Gewaily; Sharon B Schwartz; Sam Sadigh; Maria P Limberis; Peter Bell; James M Wilson; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-15       Impact factor: 4.799

5.  Vision Loss in a Teenage Girl With Postconcussion Syndrome.

Authors:  Hasenin Al-Khersan; Tim Hain; Michael A Grassi
Journal:  JAMA Ophthalmol       Date:  2017-01-01       Impact factor: 7.389

6.  ABCA4 disease progression and a proposed strategy for gene therapy.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Yaroslav Tsybovsky; Sharon B Schwartz; Elizabeth A M Windsor; Alejandro J Roman; Alexander Sumaroka; Janet D Steinberg; Samuel G Jacobson; Edwin M Stone; Krzysztof Palczewski
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

7.  Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II.

Authors:  Denise Yan; Xiaomei Ouyang; D Michael Patterson; Li Lin Du; Samuel G Jacobson; Xue-Zhong Liu
Journal:  J Hum Genet       Date:  2009-10-30       Impact factor: 3.172

8.  Cone structure in patients with usher syndrome type III and mutations in the Clarin 1 gene.

Authors:  Kavitha Ratnam; Hanna Västinsalo; Austin Roorda; Eeva-Marja K Sankila; Jacque L Duncan
Journal:  JAMA Ophthalmol       Date:  2013-01       Impact factor: 7.389

9.  CLRN1 is nonessential in the mouse retina but is required for cochlear hair cell development.

Authors:  Scott F Geller; Karen I Guerin; Meike Visel; Aaron Pham; Edwin S Lee; Amiel A Dror; Karen B Avraham; Toshinori Hayashi; Catherine A Ray; Thomas A Reh; Olivia Bermingham-McDonogh; William J Triffo; Shaowen Bao; Juha Isosomppi; Hanna Västinsalo; Eeva-Marja Sankila; John G Flannery
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

10.  Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.

Authors:  Juha Isosomppi; Hanna Västinsalo; Scott F Geller; Elise Heon; John G Flannery; Eeva-Marja Sankila
Journal:  Mol Vis       Date:  2009-09-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.